Sutimlimab, a first-in-class complement protein component 1, s subcomponent (C1s) ингибитор, can be used for the research of cold agglutinin disease. C1s is a serine protease which cleaves C4 and C2 to form the C3 convertase.
Sutimlimab, a first-in-class complement protein component 1, s subcomponent (C1s) inhibitor, can be used for the research of cold agglutinin disease. C1s is a serine protease which cleaves C4 and C2 to form the C3 convertase.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.